Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Micardil 25 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Micardil 25

Approved

STANDARD

Micardil 25

Zim Laboratories Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 83720f1bde60d7c7
Company: Zim Laboratories Limited
Type: Standard

Approval Details

Approval Id: 83720f1bde60d7c7
Drug Approval Philippines Name: Micardil 25
Product Name: Micardil 25
Registration Number: DRP-4463-06
Brand Name: Micardil 25
Generic Name: Carvedilol
Dosage Form: Tablet
Dosage Strength: 25 mg
Manufacturer: Zim Laboratories Limited
Trader: Rainbow Life Sciences Pvt. Ltd
Importer: Ambica International Corporation
Distributor: Rule Med Pharma Corp
Issuance Date: 27 January 2025
Expiry Date: 04 June 2028
Pharmacologic Category: Combined Alpha and Beta-Adrenoceptor Blocker
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

83720f1bde60d7c7

Type

Standard

Back to Philippines FDA Approvals